Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Ludolph

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Frontiers in Aging Neuroscience|March 31, 2018
Atrophy in the Thalamus But Not Cerebellum Is Specific for <i>C9orf72</i> FTD and ALS Patients - An Atlas-Based Volumetric MRI StudySonja Schönecker, Christiane Neuhofer, Markus Otto, et al.
Alzheimer Disease and Associated Disorders|January 10, 2022
Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive AphasiaMustafa Seckin, Ingrid Ricard, Theresa Raiser, et al.
European Journal of Neurology|June 11, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter studyThomas Meyer, Marie Dreger, Torsten Grehl, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020)Elisabeth C Inwald, Christian Albring, Erika Baum, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 6, 2025
Toward therapeutic trials in primary lateral sclerosisErica Scirocco, Matti D Allen, Elisa Giacomelli, et al.
JAMA Neurology|March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical TrialJeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALSStacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Nature Medicine|June 3, 2021
Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
Nature Medicine|April 16, 2021
Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Frontiers in Aging Neuroscience|March 31, 2018
Atrophy in the Thalamus But Not Cerebellum Is Specific for <i>C9orf72</i> FTD and ALS Patients - An Atlas-Based Volumetric MRI StudySonja Schönecker, Christiane Neuhofer, Markus Otto, et al.
Alzheimer Disease and Associated Disorders|January 10, 2022
Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive AphasiaMustafa Seckin, Ingrid Ricard, Theresa Raiser, et al.
European Journal of Neurology|June 11, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter studyThomas Meyer, Marie Dreger, Torsten Grehl, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020)Elisabeth C Inwald, Christian Albring, Erika Baum, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 6, 2025
Toward therapeutic trials in primary lateral sclerosisErica Scirocco, Matti D Allen, Elisa Giacomelli, et al.
JAMA Neurology|March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical TrialJeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALSStacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Nature Medicine|June 3, 2021
Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
Nature Medicine|April 16, 2021
Altered perivascular fibroblast activity precedes ALS disease onsetAnna Månberg, Nathan Skene, Folkert Sanders, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Pageof 12